Filing Details
- Accession Number:
- 0001453814-18-000120
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-09-06 16:45:47
- Reporting Period:
- 2018-09-04
- Accepted Time:
- 2018-09-06 16:45:47
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1453814 | Medidata Solutions Inc. | MDSO | Services-Prepackaged Software (7372) | 522319066 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1641826 | Rouven Bergmann | C/O Medidata Solutions, Inc. 350 Hudson Street, 9Th Floor New York NY 10014 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2018-09-04 | 20,000 | $53.29 | 98,862 | No | 4 | M | Direct | |
Common Stock | Disposition | 2018-09-04 | 20,000 | $84.24 | 78,862 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Acquisiton | 2018-09-04 | 20,000 | $0.00 | 20,000 | $53.29 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
37,643 | 2025-05-13 | No | 4 | M | Direct |
Footnotes
- The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 26, 2018.
- Such transaction was executed in multiple trades at prices ranging from $83.91 to $84.86. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- The options vested as to 25% of the shares on May 13, 2016 and 1/36th of the remaining options will become exercisable each month thereafter for the next 36 months.